Exact Sciences
EXAS
#1384
Rank
€11.80 B
Marketcap
63,92 €
Share price
2.34%
Change (1 day)
-9.27%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

EPS for Exact Sciences (EXAS)

EPS in 2023 (TTM): -1,47 €

According to Exact Sciences's latest financial reports the company's current EPS (TTM) is -1,43 €. In 2022 the company made an earnings per share (EPS) of -3,19 € a decrease over its 2021 EPS that were of -3,12 €.

EPS history for Exact Sciences from 2001 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-1,47 €-54.11%
2022-3,19 €2.31%
2021-3,12 €-37.09%
2020-4,96 €674.65%
2019-0,64 €-50.69%
2018-1,30 €44%
2017-0,90 €-39.39%
2016-1,49 €-2.94%
2015-1,53 €37.1%
2014-1,12 €79.71%
2013-0,62 €-21.59%
2012-0,79 €62.96%
2011-0,49 €92.86%
2010-0,25 €-3.45%
2009-0,26 €-19.44%
2008-0,32 €-18.18%
2007-0,40 €-10.2%
2006-0,44 €-10.91%
2005-0,50 €-24.66%
2004-0,66 €-51.33%
2003-1,35 €-7.41%
2002-1,46 €11.72%
2001-1,31 €

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-2,74 € 91.72%🇺🇸 USA
0,31 €-121.44%🇺🇸 USA
-0,36 €-74.77%🇺🇸 USA
-45,93 € 3,110.12%🇺🇸 USA
2,87 €-300.57%🇫🇷 France